NIH begins clinical trial of hydroxychloroquine and azithromycin to treat coronavirus patients

On Thursday, the NIH announced it has begun a clinical trial testing a combination of the antibiotic azithromycin and the anti-malaria drug hydroxychloroquine in coronavirus patients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news